Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 2580 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  Instructions 
  Search 
  IPS 
  My preferences 

 


This article has been cited by
1Brexpiprazole: A Review in Schizophrenia
James E. Frampton
Drugs.2019;79(2)189
[DOI]
2Perceptions of Psychiatrists Toward the Use of Long-Acting Injectable Antipsychotics
Sandeep Grover,Swapnajeet Sahoo,Aseem Mehra
Journal of Clinical Psychopharmacology.2019;39(6)611
[DOI]
3Clozapine and hematologic adverse reactions: Impact of the Risk Evaluation and Mitigation Strategy program
Eric P. Borrelli,Erica Y. Lee,Aisling R. Caffrey
Mental Health Clinician.2020;10(3)70
[DOI]
4ECT in schizophrenia: a review of the evidence
Sandeep Grover,Swapnajeet Sahoo,Anjumoni Rabha,Raman Koirala
Acta Neuropsychiatrica.2019;31(03)115
[DOI]
5A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacistsí Interventions on Patient Outcome
Mercy N. A. Opare-Addo,Josephine Mensah,Grace Owusu Aboagye
Case Reports in Psychiatry.2020;2020(03)1
[DOI]
6Recent advances in the development of asenapine formulations
Akhil Suresh,Reema Narayan,Usha Y Nayak
Expert Opinion on Drug Delivery.2020;2020(03)1
[DOI]